Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
Clinical trial NCT05059587 · COMPLETED
Trial details
- NCT number
- NCT05059587
- Sponsor
- Medytox Korea
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2021-12-29
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.